These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 15234645

  • 1. Risk of serious upper gastrointestinal and cardiovascular thromboembolic complications with meloxicam.
    Singh G, Lanes S, Triadafilopoulos G.
    Am J Med; 2004 Jul 15; 117(2):100-6. PubMed ID: 15234645
    [Abstract] [Full Text] [Related]

  • 2. Review of clinical trials and benefit/risk ratio of meloxicam.
    Barner A.
    Scand J Rheumatol Suppl; 1996 Jul 15; 102():29-37. PubMed ID: 8628979
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-scale Evaluation of COX-inhibiting Therapies (SELECT) trial in osteoarthritis.
    Dequeker J, Hawkey C, Kahan A, Steinbrück K, Alegre C, Baumelou E, Bégaud B, Isomäki H, Littlejohn G, Mau J, Papazoglou S.
    Br J Rheumatol; 1998 Sep 15; 37(9):946-51. PubMed ID: 9783758
    [Abstract] [Full Text] [Related]

  • 5. The risk of gastrointestinal bleed, myocardial infarction, and newly diagnosed hypertension in users of meloxicam, diclofenac, naproxen, and piroxicam.
    Jick SS.
    Pharmacotherapy; 2000 Jul 15; 20(7):741-4. PubMed ID: 10907963
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A double-blind study to compare the efficacy and safety of meloxicam 15 mg with piroxicam 20 mg in patients with osteoarthritis of the hip.
    Lindén B, Distel M, Bluhmki E.
    Br J Rheumatol; 1996 Apr 15; 35 Suppl 1():35-8. PubMed ID: 8630634
    [Abstract] [Full Text] [Related]

  • 8. Modelling therapeutic strategies in the treatment of osteoarthritis: an economic evaluation of meloxicam versus diclofenac and piroxicam.
    Tavakoli M.
    Pharmacoeconomics; 2003 Apr 15; 21(6):443-54. PubMed ID: 12678570
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A randomized, double-blind clinical trial of two doses of meloxicam compared with naproxen in children with juvenile idiopathic arthritis: short- and long-term efficacy and safety results.
    Ruperto N, Nikishina I, Pachanov ED, Shachbazian Y, Prieur AM, Mouy R, Joos R, Zulian F, Schwarz R, Artamonova V, Emminger W, Bandeira M, Buoncompagni A, Foeldvari I, Falcini F, Baildam E, Kone-Paut I, Alessio M, Gerloni V, Lenhardt A, Martini A, Hanft G, Sigmund R, Simianer S, Pediatric Rheumatology International Trials Organization.
    Arthritis Rheum; 2005 Feb 15; 52(2):563-72. PubMed ID: 15692986
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the incidence rates of selected gastrointestinal events reported for patients prescribed celecoxib and meloxicam in general practice in England using prescription-event monitoring (PEM) data.
    Layton D, Hughes K, Harris S, Shakir SA.
    Rheumatology (Oxford); 2003 Nov 15; 42(11):1332-41. PubMed ID: 12810929
    [Abstract] [Full Text] [Related]

  • 16. A comparison of the local tolerability, safety and efficacy of meloxicam and piroxicam suppositories in patients with osteoarthritis: a single-blind, randomized, multicentre study.
    Carrabba M, Paresce E, Angelini M, Galanti A, Marini MG, Cigarini P.
    Curr Med Res Opin; 1995 Nov 15; 13(6):343-55. PubMed ID: 8829892
    [Abstract] [Full Text] [Related]

  • 17. Meloxicam in osteoarthritis: a 6-month, double-blind comparison with diclofenac sodium.
    Hosie J, Distel M, Bluhmki E.
    Br J Rheumatol; 1996 Apr 15; 35 Suppl 1():39-43. PubMed ID: 8630635
    [Abstract] [Full Text] [Related]

  • 18. Gastrointestinal tolerability of meloxicam and piroxicam: a double-blind placebo-controlled study.
    Lipscomb GR, Wallis N, Armstrong G, Rees WD.
    Br J Clin Pharmacol; 1998 Aug 15; 46(2):133-7. PubMed ID: 9723821
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy and tolerability of intramuscular and oral meloxicam in patients with acute lumbago: a comparison with intramuscular and oral piroxicam.
    Bosch HC, Sigmund R, Hettich M.
    Curr Med Res Opin; 1997 Aug 15; 14(1):29-38. PubMed ID: 9524791
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.